126 related articles for article (PubMed ID: 25255040)
1. Discovery of systematic responses and potential biomarkers induced by ochratoxin A using metabolomics.
Xia K; He X; Dai Q; Cheng WH; Qi X; Guo M; Luo Y; Huang K; Zhao C; Xu W
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2014; 31(11):1904-13. PubMed ID: 25255040
[TBL] [Abstract][Full Text] [Related]
2. Metabonomic study of ochratoxin a toxicity in rats after repeated administration: phenotypic anchoring enhances the ability for biomarker discovery.
Sieber M; Wagner S; Rached E; Amberg A; Mally A; Dekant W
Chem Res Toxicol; 2009 Jul; 22(7):1221-31. PubMed ID: 19610676
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics analysis underlay mechanisms in the renal impairment of mice caused by combination of aflatoxin M1 and ochratoxin A.
Wang Z; Gao Y; Huang X; Huang S; Yang X; Wang J; Zheng N
Toxicology; 2021 Jun; 458():152835. PubMed ID: 34126166
[TBL] [Abstract][Full Text] [Related]
4. Biotransformation and nephrotoxicity of ochratoxin B in rats.
Mally A; Keim-Heusler H; Amberg A; Kurz M; Zepnik H; Mantle P; Völkel W; Hard GC; Dekant W
Toxicol Appl Pharmacol; 2005 Aug; 206(1):43-53. PubMed ID: 15963343
[TBL] [Abstract][Full Text] [Related]
5. Sex- and strain-specific expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats.
Pfohl-Leszkowicz A; Pinelli E; Bartsch H; Mohr U; Castegnaro M
Mol Carcinog; 1998 Oct; 23(2):76-85. PubMed ID: 9808161
[TBL] [Abstract][Full Text] [Related]
6. GC-MS-based metabolomics reveals mechanism of action for hydrazine induced hepatotoxicity in rats.
Bando K; Kunimatsu T; Sakai J; Kimura J; Funabashi H; Seki T; Bamba T; Fukusaki E
J Appl Toxicol; 2011 Aug; 31(6):524-35. PubMed ID: 21154879
[TBL] [Abstract][Full Text] [Related]
7. Ochratoxin A exposure biomarkers in the Czech Republic and comparison with foreign countries.
Malir F; Ostry V; Pfohl-Leszkowicz A; Roubal T
Biomarkers; 2012 Nov; 17(7):577-89. PubMed ID: 22642623
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics analysis of metabolic effects of nicotinamide phosphoribosyltransferase (NAMPT) inhibition on human cancer cells.
Tolstikov V; Nikolayev A; Dong S; Zhao G; Kuo MS
PLoS One; 2014; 9(12):e114019. PubMed ID: 25486521
[TBL] [Abstract][Full Text] [Related]
9. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity.
Adler M; Müller K; Rached E; Dekant W; Mally A
Carcinogenesis; 2009 Apr; 30(4):711-9. PubMed ID: 19237604
[TBL] [Abstract][Full Text] [Related]
10. Ochratoxin A: developmental and reproductive toxicity-an overview.
Malir F; Ostry V; Pfohl-Leszkowicz A; Novotna E
Birth Defects Res B Dev Reprod Toxicol; 2013 Dec; 98(6):493-502. PubMed ID: 24395216
[TBL] [Abstract][Full Text] [Related]
11. H NMR spectroscopy-based metabolomic assessment of uremic toxicity, with toxicological outcomes, in male rats following an acute, mid-life insult from ochratoxin a.
Mantle PG; Nicholls AW; Shockcor JP
Toxins (Basel); 2011 Jun; 3(6):504-19. PubMed ID: 22069722
[TBL] [Abstract][Full Text] [Related]
12. DNA adduct formation by ochratoxin A: review of the available evidence.
Mally A; Dekant W
Food Addit Contam; 2005; 22 Suppl 1():65-74. PubMed ID: 16332624
[TBL] [Abstract][Full Text] [Related]
13. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in rat.
Marin-Kuan M; Nestler S; Verguet C; Bezençon C; Piguet D; Mansourian R; Holzwarth J; Grigorov M; Delatour T; Mantle P; Cavin C; Schilter B
Toxicol Sci; 2006 Jan; 89(1):120-34. PubMed ID: 16251485
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin a in vivo and in vitro.
Rached E; Hoffmann D; Blumbach K; Weber K; Dekant W; Mally A
Toxicol Sci; 2008 Jun; 103(2):371-81. PubMed ID: 18308701
[TBL] [Abstract][Full Text] [Related]
15. Ochratoxin A: Toxicity, oxidative stress and metabolism.
Tao Y; Xie S; Xu F; Liu A; Wang Y; Chen D; Pan Y; Huang L; Peng D; Wang X; Yuan Z
Food Chem Toxicol; 2018 Feb; 112():320-331. PubMed ID: 29309824
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of lycopene against ochratoxin A induced renal oxidative stress and apoptosis in rats.
Palabiyik SS; Erkekoglu P; Zeybek ND; Kizilgun M; Baydar DE; Sahin G; Giray BK
Exp Toxicol Pathol; 2013 Sep; 65(6):853-61. PubMed ID: 23332503
[TBL] [Abstract][Full Text] [Related]
17. Ochratoxin A as a potential etiologic factor in endemic nephropathy: lessons from toxicity studies in rats.
Mally A; Hard GC; Dekant W
Food Chem Toxicol; 2007 Nov; 45(11):2254-60. PubMed ID: 17629386
[TBL] [Abstract][Full Text] [Related]
18. [Calcium concentration in the skin of male rats exposed to high doses of ochratoxin A (OTA)].
Bulikowski W; Borzecki A; Skorupski R; Trocka K; Lingas W
Med Pr; 2005; 56(5):363-6. PubMed ID: 16483006
[TBL] [Abstract][Full Text] [Related]
19. Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats.
Mally A; Völkel W; Amberg A; Kurz M; Wanek P; Eder E; Hard G; Dekant W
Chem Res Toxicol; 2005 Aug; 18(8):1242-52. PubMed ID: 16097797
[TBL] [Abstract][Full Text] [Related]
20. Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344/n rats.
Rached E; Hard GC; Blumbach K; Weber K; Draheim R; Lutz WK; Ozden S; Steger U; Dekant W; Mally A
Toxicol Sci; 2007 Jun; 97(2):288-98. PubMed ID: 17344223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
